United States · 
Who invested in Medisas?
Medisas's investors include Y Combinator, Andreessen Horowitz, FundersClub, SV Angel and Khosla Ventures, and 2 more on record.
2013201420152016
?Seed$11MSeries A
United States · Series A startup
Who invested in Medisas
Funding summaryUpdated 26 Oct 2026
$11Mraised across 2 rounds since 2013, from 2 sources
- Latest round
- Series A, $11MDec 2016
- Investors
- 7
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed Mar 2013
- Biggest round
- $11M Series A · Dec 2016
- Between rounds
- 3.8 years from the last two
The rounds
- Dec 2016Series A$11M2 new3 returning
Source recordedSEC filing: $11M sold, first sale Dec 2016
- Mar 2013SeedAmount undisclosed5 new
From a historical funding record
Founders and team
From Medisas's own website and the SEC filings it signed: 1 on the team.
- Gautam SivakumarExecutive Officer, Director, Promoteri
AdvisersJeff DeanKeith Rabois
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Medisas
How much has Medisas raised?
Medisas has raised $11M across 2 rounds since 2013. One round did not disclose an amount, so the total is a floor.
When did Medisas last raise?
Medisas's most recent round was a Series A of $11M in Dec 2016.
What was Medisas's biggest round?
Its most recent round, $11M in Dec 2016, is also its largest on record.
Who backed Medisas first?
Medisas's first round on record, in Mar 2013, was backed by Y Combinator, Andreessen Horowitz and SV Angel and 2 others.
What stage is Medisas at?
Medisas's latest named round is a Series A, in Dec 2016.
Where is Medisas based?
Medisas is based in the United States.
Companies like Medisas
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.